US5496280A
(en)
|
1992-07-02 |
1996-03-05 |
Applied Medical Resources Corporation |
Trocar valve assembly
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
|
ES2320955B1
(es)
*
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
ES2329639B1
(es)
|
2007-04-26 |
2010-09-23 |
Laboratorios Almirall S.A. |
Nuevos derivados de 4,8-difenilpoliazanaftaleno.
|
TW200927731A
(en)
|
2007-09-14 |
2009-07-01 |
Ortho Mcneil Janssen Pharm |
1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
|
EA019085B1
(ru)
|
2007-09-14 |
2014-01-30 |
Янссен Фармасьютикалз, Инк. |
1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
|
US9114138B2
(en)
|
2007-09-14 |
2015-08-25 |
Janssen Pharmaceuticals, Inc. |
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
|
JP5433582B2
(ja)
|
2007-11-14 |
2014-03-05 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
イミダゾ[1,2−a]ピリジン誘導体およびmGluR2受容体の正のアロステリック調節因子としてのその使用
|
EP2108641A1
(de)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
Neue substituierte Spiro[Cycloalkyl-1,3'-indo]-2'(1'H)-on-Derivate und ihre Verwendung als p38 mitogen-activated Kinase Inhibitoren
|
EP2113503A1
(de)
*
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
Neue substituierte Indolin-2-on- Derivate und ihre Verwendung als p39 mitogen-activated Kinase Inhibitoren
|
WO2010025890A1
(en)
|
2008-09-02 |
2010-03-11 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
AU2009304293B2
(en)
|
2008-10-16 |
2012-04-26 |
Addex Pharma S.A. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
AU2009319387B2
(en)
|
2008-11-28 |
2012-05-10 |
Addex Pharma S.A. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
CA2760259C
(en)
|
2009-05-12 |
2018-05-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JP5634506B2
(ja)
|
2009-05-12 |
2014-12-03 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド |
1,2,3−トリアゾロ[4,3−a]ピリジン誘導体ならびに神経障害および精神障害の治療または予防のためのその使用
|
MY153913A
(en)
*
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
TWI500614B
(zh)
|
2009-06-05 |
2015-09-21 |
Cephalon Inc |
1,2,4-三唑並〔1,5a〕吡啶衍生物之製備和用途
|
EP2322176A1
(de)
*
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
Neue 7-Phenyl-[1,2,4]triazol[4,3-a]pyridin-3(2H)on-Derivate
|
EP2338888A1
(de)
*
|
2009-12-24 |
2011-06-29 |
Almirall, S.A. |
Imidazopyridin-Derivate als JAK-Inhibitoren
|
UY33213A
(es)
|
2010-02-18 |
2011-09-30 |
Almirall Sa |
Derivados de pirazol como inhibidores de jak
|
JP5852666B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
ES2552455T3
(es)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
JP5852665B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
EP2642998B1
(de)
|
2010-11-24 |
2020-09-16 |
The Trustees of Columbia University in the City of New York |
Non-retinoider rbp4-antagonist zur behandlung von altersbedingter makuladegeneration und morbus stargardt
|
EP2463289A1
(de)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]Pyridazin-Derivate als AS JAK-Hemmer
|
EP2554544A1
(de)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1H-)-on-Derivate als JAK-Inhibitoren
|
RU2014121983A
(ru)
|
2011-10-31 |
2015-12-10 |
Ксенон Фармасьютикалз Инк. |
Биарильные простоэфирные сульфонамиды и их применение в качестве терапевтических средств
|
US9630929B2
(en)
|
2011-10-31 |
2017-04-25 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
US10531655B2
(en)
|
2011-12-02 |
2020-01-14 |
The Regents Of The University Of California |
Reperfusion protection solution and uses thereof
|
WO2013166037A1
(en)
|
2012-05-01 |
2013-11-07 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of eye disorders
|
US8952169B2
(en)
|
2012-05-22 |
2015-02-10 |
Xenon Pharmaceuticals Inc. |
N-substituted benzamides and methods of use thereof
|
EP2870138B1
(de)
|
2012-07-06 |
2018-08-22 |
Genentech, Inc. |
N-substituierte benzamide und verfahren zur verwendung davon
|
WO2014051698A1
(en)
|
2012-09-28 |
2014-04-03 |
Vanderbilt University |
Fused heterocyclic compounds as selective bmp inhibitors
|
CA2898679A1
(en)
*
|
2013-03-14 |
2014-09-25 |
Xenon Pharmaceuticals Inc. |
Substituted triazolopyridines and methods of use thereof
|
WO2014151959A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
EP2968304B1
(de)
|
2013-03-14 |
2018-10-10 |
The Trustees of Columbia University in the City of New York |
4-phenylpiperidine, deren herstellung und verwendung
|
EP2968303B1
(de)
|
2013-03-14 |
2018-07-04 |
The Trustees of Columbia University in the City of New York |
Octahydrocyclopentapyrrole und deren herstellung und verwendung
|
WO2014151936A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles, their preparation and use
|
EP2970156B1
(de)
|
2013-03-15 |
2018-07-25 |
Genentech, Inc. |
Substituierte benzoxazole und verfahren zur verwendung davon
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
CN105793238B
(zh)
|
2013-11-27 |
2019-12-24 |
基因泰克公司 |
经取代的苯甲酰胺及其使用方法
|
GB201321742D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321740D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
WO2015110435A1
(en)
|
2014-01-21 |
2015-07-30 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
LT3096790T
(lt)
|
2014-01-21 |
2019-10-10 |
Janssen Pharmaceutica, N.V. |
Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
|
BR112016018555B1
(pt)
|
2014-02-13 |
2024-01-23 |
Incyte Holdings Corporation |
Ciclopropilaminas como inibidores de lsd1, seu uso, composição farmacêutica que os compreende e método de inibição de lsd1
|
ES2672797T3
(es)
|
2014-02-13 |
2018-06-18 |
Incyte Corporation |
Ciclopropilaminas como inhibidores de LSD1
|
WO2015123437A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
SG11201606689VA
(en)
|
2014-02-13 |
2016-09-29 |
Incyte Corp |
Cyclopropylamines as lsd1 inhibitors
|
DK3137168T3
(da)
|
2014-04-30 |
2022-03-21 |
Univ Columbia |
Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse
|
US10005724B2
(en)
|
2014-07-07 |
2018-06-26 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
US9695167B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
|
ES2971157T3
(es)
*
|
2014-10-06 |
2024-06-03 |
Apm Therapeutics 1 Inc |
Compuestos de triazolopiridina y métodos para el tratamiento de la fibrosis quística
|
US9944647B2
(en)
|
2015-04-03 |
2018-04-17 |
Incyte Corporation |
Heterocyclic compounds as LSD1 inhibitors
|
EP3088390A1
(de)
*
|
2015-04-30 |
2016-11-02 |
Bayer CropScience AG |
Katalytische hydrierung von substituierten cyanopyridinen
|
MX2017014715A
(es)
|
2015-05-22 |
2018-03-16 |
Genentech Inc |
Benzamidas sustituidas y metodos para utilizarlas.
|
US10329255B2
(en)
|
2015-08-12 |
2019-06-25 |
Incyte Corporation |
Salts of an LSD1 inhibitor
|
WO2017035271A1
(en)
|
2015-08-27 |
2017-03-02 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
EP3356360A1
(de)
|
2015-09-28 |
2018-08-08 |
Genentech, Inc. |
Therapeutische verbindungen und verfahren zur verwendung davon
|
US10899732B2
(en)
|
2015-11-25 |
2021-01-26 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
CN109071426A
(zh)
|
2016-03-30 |
2018-12-21 |
基因泰克公司 |
取代的苯甲酰胺及其使用方法
|
AU2017252328B2
(en)
|
2016-04-22 |
2023-02-23 |
Incyte Corporation |
Formulations of an LSD1 inhibitor
|
RU2019114964A
(ru)
|
2016-10-17 |
2020-11-17 |
Дженентек, Инк. |
Терапевтические средства и способы их применения
|
JP2020511511A
(ja)
|
2017-03-24 |
2020-04-16 |
ジェネンテック, インコーポレイテッド |
ナトリウムチャネル阻害剤としての4−ピペリジン−n−(ピリミジン−4−イル)クロマン−7−スルホンアミド誘導体
|
CN111051305A
(zh)
*
|
2017-08-22 |
2020-04-21 |
吉利德科学公司 |
治疗性杂环化合物
|
WO2019071147A1
(en)
|
2017-10-05 |
2019-04-11 |
Fulcrum Therapeutics, Inc. |
INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
US11028075B2
(en)
|
2018-02-26 |
2021-06-08 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
US10745400B2
(en)
|
2018-03-14 |
2020-08-18 |
Vanderbuilt University |
Inhibition of BMP signaling, compounds, compositions and uses thereof
|
EP3774801A1
(de)
|
2018-03-30 |
2021-02-17 |
F. Hoffmann-La Roche AG |
Hydro-pyrido-verbindungen mit kondensierten ringen als natriumkanalinhibitoren
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
CN111116582B
(zh)
*
|
2019-12-18 |
2022-07-29 |
大连大学 |
一种mGluR2拮抗剂
|
CN114516870B
(zh)
*
|
2022-02-10 |
2023-04-11 |
五邑大学 |
一种三唑并六元氮杂环-3-胺类化合物及其制备方法和应用
|